# Evaluation of Two Different Non-invasive Techniques to Monitor the Clearance of Actinic Keratosis Lesions

> **NCT00294320** · PHASE3 · COMPLETED · sponsor: **MEDA Pharma GmbH & Co. KG** · enrollment: 12 (actual)

## Conditions studied

- Actinic Keratosis

## Interventions

- **DRUG:** Aldara (Imiquimod)
- **OTHER:** Vehicle cream

## Key facts

- **NCT ID:** NCT00294320
- **Lead sponsor:** MEDA Pharma GmbH & Co. KG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-02
- **Primary completion:** 2007-01
- **Final completion:** 2007-01
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2022-02-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00294320

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00294320, "Evaluation of Two Different Non-invasive Techniques to Monitor the Clearance of Actinic Keratosis Lesions". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00294320. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*